Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Oct 07, 2024

SELL
$165.67 - $199.94 $6.02 Million - $7.27 Million
-36,341 Reduced 11.6%
277,073 $46.9 Million
Q1 2024

May 09, 2024

SELL
$165.67 - $199.94 $6.02 Million - $7.27 Million
-36,341 Reduced 11.6%
277,073 $46.9 Million
Q4 2023

Oct 07, 2024

SELL
$151.44 - $200.09 $6.8 Million - $8.98 Million
-44,886 Reduced 12.53%
313,414 $61.9 Million
Q4 2023

Feb 12, 2024

SELL
$151.44 - $200.09 $6.8 Million - $8.98 Million
-44,886 Reduced 12.53%
313,414 $61.9 Million
Q2 2023

Oct 07, 2024

BUY
$160.94 - $186.23 $6.87 Million - $7.95 Million
42,700 Added 13.53%
358,300 $61.7 Million
Q2 2023

Aug 14, 2023

BUY
$160.94 - $186.23 $6.87 Million - $7.95 Million
42,700 Added 13.53%
358,300 $61.7 Million
Q1 2023

Oct 07, 2024

BUY
$145.48 - $175.02 $8.22 Million - $9.89 Million
56,500 Added 21.81%
315,600 $52.5 Million
Q1 2023

May 12, 2023

BUY
$145.48 - $175.02 $8.22 Million - $9.89 Million
56,500 Added 21.81%
315,600 $52.5 Million
Q4 2022

Oct 07, 2024

BUY
$131.14 - $157.47 $34 Million - $40.8 Million
259,100 New
259,100 $38 Million
Q4 2022

Feb 10, 2023

SELL
$131.14 - $157.47 $1.16 Million - $1.39 Million
-8,809 Reduced 3.29%
259,100 $38 Million
Q3 2022

Nov 14, 2022

SELL
$148.29 - $182.55 $2.97 Million - $3.65 Million
-20,001 Reduced 6.95%
267,909 $39.7 Million
Q2 2022

Aug 12, 2022

SELL
$155.97 - $200.09 $64.9 Million - $83.2 Million
-416,051 Reduced 59.1%
287,910 $49.5 Million
Q1 2022

May 13, 2022

SELL
$181.39 - $234.03 $39.8 Million - $51.4 Million
-219,617 Reduced 23.78%
703,961 $133 Million
Q4 2021

Feb 11, 2022

SELL
$193.69 - $247.03 $23.4 Million - $29.9 Million
-121,013 Reduced 11.58%
923,578 $225 Million
Q3 2021

Nov 09, 2021

SELL
$189.29 - $209.69 $70.7 Million - $78.3 Million
-373,308 Reduced 26.33%
1,044,591 $203 Million
Q2 2021

Aug 11, 2021

BUY
$155.9 - $187.99 $176 Million - $212 Million
1,127,067 Added 387.53%
1,417,899 $264 Million
Q1 2021

May 11, 2021

SELL
$144.0 - $169.39 $61 Million - $71.8 Million
-423,616 Reduced 59.29%
290,832 $45.8 Million
Q4 2020

Feb 09, 2021

BUY
$157.07 - $174.35 $3.23 Million - $3.58 Million
20,550 Added 2.96%
714,448 $118 Million
Q3 2020

Nov 12, 2020

BUY
$137.1 - $165.37 $6.63 Million - $7.99 Million
48,343 Added 7.49%
693,898 $115 Million
Q2 2020

Aug 14, 2020

SELL
$111.92 - $142.53 $8.96 Million - $11.4 Million
-80,062 Reduced 11.03%
645,555 $88.5 Million
Q1 2020

May 14, 2020

BUY
$92.66 - $144.94 $11.3 Million - $17.7 Million
121,907 Added 20.19%
725,617 $85.4 Million
Q4 2019

Feb 14, 2020

SELL
$116.25 - $133.25 $20.2 Million - $23.1 Million
-173,420 Reduced 22.32%
603,710 $79.9 Million
Q3 2019

Nov 14, 2019

SELL
$112.57 - $128.43 $2.05 Million - $2.33 Million
-18,172 Reduced 2.28%
777,130 $96.8 Million
Q2 2019

Aug 14, 2019

BUY
$97.98 - $114.28 $37.6 Million - $43.9 Million
384,212 Added 93.46%
795,302 $90.3 Million
Q1 2019

May 15, 2019

SELL
$81.56 - $100.67 $22.3 Million - $27.5 Million
-272,828 Reduced 39.89%
411,090 $41.4 Million
Q4 2018

Feb 14, 2019

BUY
$79.28 - $95.27 $18.3 Million - $21.9 Million
230,277 Added 50.76%
683,918 $58.5 Million
Q3 2018

Nov 14, 2018

SELL
$83.5 - $93.23 $9.23 Million - $10.3 Million
-110,569 Reduced 19.6%
453,641 $41.5 Million
Q2 2018

Aug 14, 2018

SELL
$79.9 - $89.2 $34.1 Million - $38 Million
-426,171 Reduced 43.03%
564,210 $48.1 Million
Q1 2018

May 15, 2018

BUY
$71.51 - $84.69 $13.8 Million - $16.4 Million
193,462 Added 24.28%
990,381 $82.7 Million
Q4 2017

Feb 14, 2018

BUY
$63.24 - $72.8 $18.6 Million - $21.5 Million
294,872 Added 58.73%
796,919 $57.4 Million
Q3 2017

Nov 14, 2017

BUY
$59.73 - $65.4 $7 Million - $7.67 Million
117,254 Added 30.47%
502,047 $32 Million
Q2 2017

Aug 14, 2017

BUY
N/A
384,793
384,793 $24 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.